Literature DB >> 17004325

Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells.

Lorna C Ewan1, Helen M Jopling, Haiyan Jia, Shweta Mittar, Azadeh Bagherzadeh, Gareth J Howell, John H Walker, Ian C Zachary, Sreenivasan Ponnambalam.   

Abstract

The human endothelial vascular endothelial growth factor receptor 2 (VEGFR2/kinase domain region, KDR/fetal liver kinase-1, Flk-1) tyrosine kinase receptor is essential for VEGF-mediated physiological responses including endothelial cell proliferation, migration and survival. How VEGFR2 kinase activation and trafficking are co-coordinated in response to VEGF-A is not known. Here, we elucidate a mechanism for endothelial VEGFR2 response to VEGF-A dependent on constitutive endocytosis co-ordinated with ligand-activated ubiquitination and proteolysis. The selective VEGFR kinase inhibitor, SU5416, blocked the endosomal sorting required for VEGFR2 trafficking and degradation. Inhibition of VEGFR2 tyrosine kinase activity did not block plasma membrane internalization but led to endosomal accumulation. Lysosomal protease activity was required for ligand-stimulated VEGFR2 degradation. Activated VEGFR2 codistributed with the endosomal hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs)/signal-transducing adaptor molecule (STAM) complex in a ligand and time-dependent manner, implying a role for this factor in sorting of ubiquitinated VEGFR2. Increased tyrosine phosphorylation of the Hrs subunit in response to VEGF-A links VEGFR2 activation and Hrs/STAM function. In contrast, VEGFR2 in quiescent cells was present on both the endothelial plasma membrane and early endosomes, suggesting constitutive recycling between these two compartments. This pathway was clathrin-linked and dependent on the AP2 adaptor complex as the A23 tyrphostin inhibited VEGFR2 trafficking. We propose a mechanism whereby the transition of endothelial VEGFR2 from a constitutive recycling itinerary to a degradative pathway explains ligand-activated receptor degradation in endothelial cells. This study outlines a mechanism to control the VEGF-A-mediated response within the vascular system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17004325     DOI: 10.1111/j.1600-0854.2006.00462.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  87 in total

1.  Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription.

Authors:  Guangqi E; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Enfeng Wang; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

Review 2.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Authors:  Wan Hua Tan; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

4.  VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.

Authors:  Vedanta Mehta; Laura Fields; Ian M Evans; Maiko Yamaji; Caroline Pellet-Many; Timothy Jones; Marwa Mahmoud; Ian Zachary
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

5.  An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury.

Authors:  Seyedtaghi Takyar; Yi Zhang; Maria Haslip; Lei Jin; Peiying Shan; Xuchen Zhang; Patty J Lee
Journal:  FASEB J       Date:  2015-12-11       Impact factor: 5.191

6.  Variants of Rab GTPase-Effector Binding Protein-2 Cause Variation in the Collateral Circulation and Severity of Stroke.

Authors:  Jennifer L Lucitti; Robert Sealock; Brian K Buckley; Hua Zhang; Lin Xiao; Andrew C Dudley; James E Faber
Journal:  Stroke       Date:  2016-11-03       Impact factor: 7.914

Review 7.  MicroRNA control of vascular endothelial growth factor signaling output during vascular development.

Authors:  Lan T H Dang; Nathan D Lawson; Jason E Fish
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

Review 8.  Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis.

Authors:  Kai Song; Hao Wu; H N Ashiqur Rahman; Yunzhou Dong; Aiyun Wen; Megan L Brophy; Scott Wong; Sukyoung Kwak; Diane R Bielenberg; Hong Chen
Journal:  Cell Mol Life Sci       Date:  2016-08-29       Impact factor: 9.261

9.  Armadillo Repeat Containing 8alpha Binds to HRS and Promotes HRS Interaction with Ubiquitinated Proteins.

Authors:  Koji Tomaru; Atsuhisa Ueda; Takeyuki Suzuki; Nobuaki Kobayashi; Jun Yang; Masaki Yamamoto; Mitsuhiro Takeno; Takeshi Kaneko; Yoshiaki Ishigatsubo
Journal:  Open Biochem J       Date:  2010-01-13

10.  VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.

Authors:  Z Zhang; K G Neiva; M W Lingen; L M Ellis; J E Nör
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.